Loading
Total declarations
Company
▲ Purchases (37 ops.)
▼ Sales (53 ops.)
Latest filing published 23 Oct 2026 for Clover Biopharmaceuticals, Ltd. - B, €8,963.
Filing timeline
BuySaleLiang Peng
Insider track record
Disclosed buys
37
Disclosed sells
53
Signal history
Closed purchases
Market purchases
37
Positive at T+90
88%
Median T+90
+47.4%
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -56.5%Entry HK$3.08 · Close 22 Oct 2026 HK$1.34
- -53.0%Entry HK$2.85 · Close 22 Oct 2026 HK$1.34
- -34.6%Entry HK$2.05 · Close 22 Oct 2026 HK$1.34
- +196.6%Entry HK$0.59 · Close at T+365 HK$1.75
- -80.7%Entry HK$3.16 · Close at T+365 HK$0.61
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Liang Peng: trading record in brief
Liang Peng (chief executive) discloses dealings in Clover Biopharmaceuticals, Ltd. - B to HKEX. Between 5 November 2021 and 21 October 2026, the trades on record add up to 130 filings.
On the open market, the record shows 37 purchases worth €609k and 53 sales worth €782k. The totals do not cover 62 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 3 purchases and 23 sales.
In size, the median ticket on the buying side is €66k. The 10 purchases reviewed show no overlap with other insiders buying the same stock within a month. For 8 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 88% of cases, with a median move of +47.4%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 23 October 2026: an open-market sale of €8,963, in Clover Biopharmaceuticals, Ltd. - B. The most recent open-market purchase was published on 9 April 2026, 198 days ago. Filings reach the HKEX feed a median of 3 days after the trade. Until a filing is published, the market cannot know about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Liang Peng
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations129 total
50,000 shares@ HK$1.58ShareXHKGHKEX:DA20261023E00197
100,000 shares@ HK$1.540.0079% mcap1.3% of flowShareXHKGHKEX:DA20261021E00225
100,000 shares@ HK$1.560.0075% mcap2.5% of flowShareXHKGHKEX:DA20261015E00093
50,000 shares@ HK$1.800.0043% mcap1.4% of flowShareXHKGHKEX:DA20261015E00091
100,000 shares@ HK$1.900.0078% mcap3.1% of flowShareXHKGHKEX:DA20261002E00062
100,000 shares@ HK$2.060.010% mcap3.2% of flowShareXHKGHKEX:DA20260923E00419
100,000 shares@ HK$2.2450.011% mcap1.8% of flowShareXHKGHKEX:DA20260914E00054
500,000 shares@ HK$1.800.033% mcap14.9% of flowShareXHKGHKEX:DA20260721E00133
50,000 shares@ HK$1.550.0029% mcap1.3% of flowShareXHKGHKEX:DA20260715E00487
50,000 shares@ HK$1.720.0032% mcap1.4% of flowShareXHKGHKEX:DA20260707E00164
50,000 shares@ HK$1.730.0032% mcap1.4% of flowShareXHKGHKEX:DA20260701E00013
100,000 shares@ HK$1.640.0060% mcap2.7% of flowShareXHKGHKEX:DA20260701E00012
100,000 shares@ HK$1.8110.0066% mcap3.0% of flowShareXHKGHKEX:DA20260629E00014
52,500 shares@ HK$2.4390.0046% mcap2.1% of flowShareXHKGHKEX:DA20260601E00003
47,500 shares@ HK$2.460.0042% mcap1.9% of flowShareXHKGHKEX:DA20260601E00004
600,000 shares@ HK$3.160.083% mcap30.8% of flowShareXHKGHKEX:DA20260424E00084
300,000 shares@ HK$3.120.041% mcap15.1% of flowShareXHKGHKEX:DA20260417E00037
189,500 sharesShareXHKGHKEX:DA20260409E00094
572,500 sharesShareXHKGHKEX:DA20260409E00092
1,326,875 sharesShareXHKGHKEX:DA20260409E00100
Canonical exit: 1 Jul 2026 (T+90)
500 sharesShareXHKGHKEX:DA20260403E00016
10,340 sharesShareXHKGHKEX:DA20260403E00015
1,145,000 sharesShareXHKGHKEX:DA20260401E00048
Canonical exit: 25 Jun 2026 (T+90)
500,000 shares@ HK$2.200.039% mcap18.2% of flowShareXHKGHKEX:DA20260318E00225
50,000 shares@ HK$2.351.0% of flowShareXHKGHKEX:DA20260127E00449
25 of 129 declarations
